Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    24353047 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Tapentadol (CG5503)
Conditions: Osteoarthritis, Knee;   Pain
Interventions: Drug: oxycodone;   Drug: placebo;   Drug: tapentadol (CG5503)
2 Completed
Has Results
A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
Condition: Low Back Pain
Interventions: Drug: tapentadol (CG5503) ER;   Drug: oxycodone CR;   Drug: placebo
3 Completed
Has Results
A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
Conditions: Pain;   Knee Osteoarthritis
Interventions: Drug: Tapentadol ER (100 to 250 mg twice daily);   Drug: Matching Placebo (twice daily);   Drug: Oxycodone  CR (20 to 50 mg twice daily)

Indicates status has not been verified in more than two years